Concourse Financial Group Securities, Inc. Talis Biomedical Corp Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$0.44 - $0.54 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.48 - $0.64 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.45 - $11.67 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.7 - $10.79 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.81 - $1.44 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$1.3 - $4.19 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$3.81 - $6.17 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$6.02 - $12.46 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$9.62 - $14.56 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$11.2 - $27.8 $0 - $0
0 New
0 $0

About Talis Biomedical Corp

TLIS Quotes by TradingView
  • Ticker TLIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,619,200
  • Market Cap $47.1M
  • Description
  • Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...
More about TLIS
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email